Schedule 13D ownership disclosure

Neumora Therapeutics Inc

Security class unavailable · CUSIP: 640979100

Event date: 2023-09-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
23.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-243053
Form type
SC 13D
Filer
AMGEN INC
CIK
CIK 318154
Filed
Sep 27, 2023
Reporting period
Sep 19, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub